Case Study #3: Athletic Performance Optimization Patient: 38-year-old male competitive age-group triathlete Chief Complaints: Declining recovery between training sessions, persistent low-grade injuries, inability to hit previous power numbers despite consistent training Baseline Assessment: IGF-1: 168 ng/mL (suboptimal for training load) Testosterone: 512 ng/dL (adequate but not optimal for performance goals) hs-CRP: 2.1 mg/L (chronic low-grade inflammation) Ferritin: 32 ng/mL (suboptimal for endurance athlete) Training metrics: 7-day recovery time after hard sessions (goal: 2-3 days) Treatment Protocol: Foundation: Address iron deficiency with supplementation, optimize nutrition timing around training Hormone optimization: Testosterone enanthate to achieve 850-950 ng/dL range Peptide therapy: Sermorelin 400 mcg nightly, 6 nights/week (timed around training schedule) Supporting interventions: Sleep optimization protocol, targeted anti-inflammatory nutrition 16-Week Results: IGF-1: 284 ng/mL (+69%) Recovery time: 2-3 days for hard sessions (71% improvement) FTP (functional threshold power): +18 watts Body composition: -2.1% body fat, +1.9 kg lean mass hs-CRP: 0.6 mg/L (normalized) Race results: Two age-group podiums in half-iron distance races Patient Report: The recovery improvement is dramatic
The on-page COA library stays accessible for review at any point in the procurement, internal compliance, or post-purchase audit cycle
186 In vitro studies have uncovered other mechanisms of action by which diazoxide suppressed proliferation of human acute leukemic T cells 204 and growth of human lung cancer cells
Cell 123(4):655667
[DOI] [PMC free article] [PubMed] [Google Scholar] 78.Kory, N
Homocysteine accumulation in human ovarian carcinoma ascitic/cystic fluids possibly caused by metabolic alteration of the methionine cycle in ovarian carcinoma cells
